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Abstract
The authors propose to define the epileptic syndromes
with continuous spikes and waves during slow sleep
(CSWS) as a cognitive or behavioral impairment
acquired during childhood, associated with a strong
activation of the interictal epileptiform discharges 
during NREM sleep – whatever focal or generalized –
and not related to another factor than the presence of
CSWS. The type of syndrome will be defined according
to the neurological and neuropsychological deficit.
These syndromes have to be classified among the local-
ization-related epileptic syndromes. Some cases are
idiopathic and others are symptomatic. Guidelines for
work-up and treatment are proposed.
Key words : Epilepsy ; sleep ; childhood ; cognitive
impairment ; continuous spike-waves.
Introduction
In 1957, Landau and Kleffner reported six chil-
dren with normal early language development who
became aphasic after the onset of minor
seizures (1). Electroencephalogram (EEG) showed
bilateral epileptiform discharges which were
prominent in the temporal regions, and the authors
suspected that persistent convulsive discharges
resulted in the functional ablation of brain areas
concerned with linguistic communication. The lan-
guage disturbance was further characterized as
auditory verbal agnosia, i.e. the impossibility to
give a semantic meaning to the phonemes, leading
to a severe expressive and receptive verbal
deficit (2). Additional observations showed that the
type of aphasia may be less severe than auditory
verbal agnosia, and that language regression
together with sleep activated epileptiform dis-
charges may occur without any clinical seizure (3-
6). Longitudinal follow-up of these children
showed that the seizures as well as the EEG abnor-
malities remit before mid-teens (3-5). The Landau-
Kleffner syndrome (LKS) was recognized by the
International League Against Epilepsy (ILAE) as a
synonymous of acquired epileptic aphasia to be
classified among the epilepsies and syndromes of
childhood undetermined whether focal or general-
ized (7).
The notion of electrical status epilepticus during
slow sleep (ESES) was proposed by Tassinari and
coworkers for a particular EEG pattern character-
ized by diffuse spike-waves occurring during at
least 85% of slow sleep and persisting on 3 or more
records over a period of at least 1 month (5, 8, 9).
The children with ESES had clinical seizures (par-
tial or generalized seizures during sleep or atypical
absences when awake), and most of them had glob-
al cognitive regression leading to severe mental
retardation. However, some of these children had
more selective language-related impairment identi-
cal to that observed in LKS. Moreover, the evolu-
tion of the epilepsy showed remission before ado-
lescence even if most patients had persistent and
sometimes severe neuropsychological sequels.
Despite the clear overlap with ESES and LKS, the
ILAE proposed to classify this syndrome separate-
ly under the name “epilepsy with continuous spike-
waves during slow-wave sleep (CSWS)” (7).
Subsequently, observations of children present-
ing types of acquired cognitive impairment other
than aphasia or dementia in association with CSWS
were reported. These included autism and more
selective cognitive impairments like frontal lobe
dysfunction (attention deficit disorder with impul-
siveness, mood swings and perseveration) (10, 11),
non-dominant hemisphere impairment (apraxia and
hemineglect) (12), opercular dysfunction (severe
oral motor dysfunction, drooling, dysarthria and
decreased speech output) (13-15), visual
agnosia (16), and learning arrest (17).
Strong activation of epileptiform discharges dur-
ing sleep leading to a CSWS pattern was already
described more than 20 years ago by Jean Aicardi
in children suffering from an epileptic syndrome
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resembling benign epilepsy with central temporal
spikes (BECTS) but with atypical features like fre-
quent brief seizures (atypical absences, focal posi-
tive or negative myoclonia) or cognitive impair-
ment (18). This atypical form of BECTS was fur-
ther characterized in the literature under the name
“pseudo Lennox syndrome” to display the fact that
sleep EEG showed diffusion of the epileptiform
discharges over whole scalp (19). This led to the
assumption that some cases of epilepsy with CSWS
were to be classified among the idiopathic partial
epileptic syndromes. On the other hand, CSWS
was reported in children with cerebral palsy show-
ing brain lesions like porencephalic cysts, polymi-
crogyria, congenital hydrocephalus or thalamic
perinatal ischemic lesions (20-24). This evidenced
that some cases of epilepsy with CSWS belong to
the group of symptomatic partial epileptic syn-
dromes.
These observations prompted authors to propose
that all these syndromes are parts of a spectrum of
acquired neuropsychological disturbances that
have in common the presence of CSWS, which
should be considered as an EEG pattern encoun-
tered in idiopathic as well as in symptomatic
epileptic syndromes (5, 23, 25, 26). However, there
is no consensus on the EEG criteria needed to
define these syndromes as cases of LKS or BECTS
with acquired cognitive impairment have been
reported without the presence of spike-waves dur-
ing at least 85% of NREM sleep (25, 27-33). This
article will attempt to define epileptic syndromes
with CSWS, to delineate its limits, to approach its
physiopathology, and to propose guidelines for its
management.
Tentative definition : the spectrum of epilepsies
with CSWS and its limits
The concept underlying a tentative delineation of
diagnostic criteria common for all types of epilep-
sies with CSWS – including LKS - is that the abun-
dant epileptic activity activated during sleep plays
a major role in the cognitive and behavioral deficits
presented by these children. Clues supporting this
concept are the followings : (1) a close temporal
relationship between cognitive deterioration and
enrichment and diffusion of the sleep discharges on
EEG has been repeatedly reported ; (2) clinical
remission is usually associated with EEG improve-
ment ; (3) there is an association between the
importance of cognitive sequels and the long 
duration of CSWS ; and (4) nearly all types of 
cognitive or behavioral disturbances (aphasia,
apraxia, agnosia, dementia, autism, executive 
dysfunction,…) have been described in association
with the CSWS pattern (3, 5, 17, 23, 25, 32,
34-37).
Therefore the authors propose to reserve the
term of epilepsy with CSWS when there is a con-
junction of two features. The first is a cognitive or
behavioral impairment acquired during childhood
(between the ages of 1 and 10 years) and not relat-
ed to another factor than the presence of CSWS, for
instances a side effect of an anti-epileptic drug
(AED), an underlying metabolic or heredo-degen-
erative disease, or a psycho-affective problem. The
second is a strong activation of the interictal epilep-
tiform discharges during sleep, which may be focal
but tend to diffuse over the whole scalp. The
threshold of at least 85 % of the NREM sleep time
occupied by the epileptiform discharges is thus not
an obligatory criteria.
According to this concept, another terminology
than CSWS would be more appropriate, for
instance “sleep spiking related cognitive impair-
ment”. However, the authors propose to keep pro-
visionally the terminology “CSWS” because it is
the terminology recognized by the ILAE.
In proposing to decrease the threshold of sleep
related epileptic activity, the authors are conscious
that the prevalence of these syndromes will be
much higher than that reported in the literature,
and that the risk of overlap with other epileptic 
syndromes or developmental disorders is increased.
Overlap may concern symptomatic generalized
epilepsies like the Lennox-Gastaut syndrome, as
well as partial idiopathic epilepsies like BECTS.
The differential diagnosis with Lennox-Gastaut
syndrome will usually be possible easily with a
prolonged video-EEG recording. The presence of
partial motor seizures will suggest epilepsy with
CSWS, whereas tonic seizures when awake or
asleep, and fast rhythms during sleep are the signa-
ture of Lennox-Gastaut syndrome (9, 25). Tonic
seizures may occur subclinically and may be
revealed only by a polygraphic sleep EEG tracing
with simultaneous EMG.
The differential diagnosis with partial idiopathic
epilepsy may be more puzzling. It is usually
assumed that children with BECTS have infrequent
and easily controlled seizures, and do not present
cognitive deficits. However, when detailed neu-
ropsychological investigations are performed, non
specific verbal as well as non verbal deficits are
found in up to 50% of the patients (29-31, 38, 39).
An interesting point is that cognitive dysfunction is
more prominent during the active phase of the dis-
ease and usually resolve with the resolution of the
epilepsy. Moreover, atypical cases presenting with
frequent and difficult-to-treat brief seizures like
focal myoclonia or atypical absences are occasion-
ally encountered (13, 18, 19, 40, 41) ; in those
atypical cases, cognitive and behavioral deficits
together with strong activation and diffusion of the
interictal epileptiform discharges during sleep are
usually found. Finally, evolution from an idiopath-
ic partial epilepsy to an epilepsy with CSWS is not
an infrequent finding, which may be precipitated
by the use of some anti-epileptic drugs (9, 28). So
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it is now largely admitted that an overlap exists
between BECTS (and other types of idiopathic par-
tial epilepsies) and epilepsies with CSWS, making
the differential diagnosis between these epileptic
conditions impossible and probably unnecessary in
border cases (25, 42). Reports of BECTS and
CSWS in members of the same families also sup-
port this view (43).
Differential diagnosis with developmental disor-
ders of the immature brain like autism and specific
language impairment can also happen. It is well
recognized that the incidence of interictal epilepti-
form discharges is much higher in children suffer-
ing one of these disorders than in controls (44-48).
It is generally assumed that these epileptiform dis-
charges do not have significant impact on the cog-
nitive or behavioral impairment, and have to be
considered as either the marker of an underlying
cerebral lesion or the genetic trait of an idiopathic
epilepsy. However, the finding of a strong activa-
tion of the interictal epileptic activity during sleep
in some cases raises the question of an overlap
between epilepsies with CSWS and these behav-
iorally defined developmental disorders. The dis-
tinction with a CSWS associated disorder, and
more specifically with LKS, should theoretically
be easily made with an anamnesis oriented to the
profile of evolution. LKS is by definition an
acquired aphasia, meaning that language was nor-
mally developing before the occurrence of regres-
sion. On the contrary, impairment from early age
with continuing progresses is the rule in specific
language impairment, whatever impairment con-
cerns expressive or receptive verbal abilities (49).
Things are more complicated in autism, defined as
impaired social interaction, language, communica-
tion, imaginative play, and range of interests and
activities starting before the age of 3 years (48).
Regression after early normal development is
reported in about one third of autistic children (50).
This suggests that children showing autistic regres-
sion are good candidates for sleep EEG studies.
This assumption was however not confirmed in a
recent study showing that the prevalence of epilep-
sy or abnormal spiking EEG was not higher in the
subgroup of autistic children with regression than
in the subgroup without any history of regres-
sion (51). So the significance of interictal epilepti-
form discharges in autism and specific language
impairment is still unclear. Well designed pharma-
cological studies are warranted in order to clarify
the role of epilepsy and interictal epileptiform dis-
charges in cognitive and behavioral impairment of
children with developmental brain disorders.
Physiopathology of the CSWS phenomenon
and of the neuropsychological deterioration
It is now largely admitted that the diffusion of
the epileptiform discharges during NREM sleep is
related to a mechanism of secondary bilateral syn-
chrony from a focal cortical onset. It is probable
that thalamic nuclei play an important role in this
phenomenon, presumably through a development
of the physiological slow-sleep oscillation into dif-
fuse slow waves because of the lack of inhibitory
constraint. This hypothesis is supported by experi-
mental CSWS-like pattern obtained in cats follow-
ing unilateral thalamic ablation (52). The role of
the thalamus in the generation of the CSWS phe-
nomenon was recently emphasized by reports of
patients showing thalamic clastic lesions on
MRI (22). Arguments in favor of a focal origin of
the CSWS phenomenon are the following : (1) in
some cases, the spike-wave complexes remain uni-
lateral during NREM sleep (5) ; (2) even in patients
showing diffuse spike-waves during sleep as well
as generalized absence-type seizures, focal onset
was suggested by careful neurophysiological study,
i.e. measurement of interhemispheric peak differ-
ences using coherence and phase analyses (53) ; (3)
unilateral intracarotid amobarbital injection per-
formed in a presurgical context of refractory LKS
cases have shown bilateral suppression of epilepti-
form activity (54, 55) ; (4) magnetoencephalo-
graphic (MEG) studies of LKS cases evaluated for
surgery suggest that the perisylvian cortex is a like-
ly pacemaker of epileptic discharges (56, 57) ; and
(5) positon emission tomography (PET) frequently
shows areas of cortical dysfunction of variable
location (12, 13, 58-60). Therefore, epilepsies with
CSWS should logically be classified among the
localization-related epileptic syndromes, of idio-
pathic or symptomatic nature.
The initial hypothesis of a “functional ablation”
of eloquent cortical areas by the “persistent convul-
sive discharge” to explain the neuropsychological
impairment, as proposed half a century ago by
Landau and Kleffner (1), remains the most largely
accepted hypothesis. However, it must be empha-
sized that some observations are not fully
explained with this theory. Firstly, the temporal
association between CSWS on EEG and neurolog-
ical regression is not always strict. This fact was
already mentioned by Landau and Kleffner and
was confirmed by other authors studying patients
with LKS using longitudinal EEG and neuropsy-
chological evaluations (2, 33, 61). Secondly, if
some authors found a strict association between the
pattern of neuropsychological derangement and the
location of the interictal focus (5), others did not.
In particular, patients showing clinical frontal dys-
function and parietal epileptic focus have been
reported (58). Thirdly, PET studies using the tracer
18F-fluorodeoxyglucose (FDG) have shown that,
contrary to patients with BECTS who usually show
a normal pattern (62), abnormalities are frequently
found in patients with CSWS investigated in the
active phase of the disease. However, the type of
PET abnormality is highly variable, ranging from
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focal or multifocal cortical hypometabolism to
focal hypermetabolism, or to the association of
hypometabolism and hypermetabolism in different
areas in the same patient (12, 13, 58-60). A tenta-
tive physiopathological hypothesis which has the
advantage to reconcile these apparent discrepancies
emerged from connectivity studies obtained from
FDG-PET data (58). This hypothesis is based on
the concept of surrounding and remote inhibition,
which has been demonstrated in animal models of
epilepsy (63, 64). It proposes that the foci of
increased glucose metabolism are the epileptic foci
(which may in some patients not be intense enough
to be imaged by PET), and that these foci inhibit
other cortical areas which may be either in the bor-
der of the hypermetabolic area (surrounding inhibi-
tion) or distant from it (remote inhibition).
Therefore, it is the location of the inhibited cortical
area which might determine the type of neuropsy-
chological profile.
Guidelines for work-up of patients with
suspected CSWS
The suspicion of CSWS will arise from cogni-
tive or behavioral dysfunction in a child with or
without known epilepsy. The first step will be to
characterize the type and the evolution of the cog-
nitive impairment. In particular, efforts to reconsti-
tute the profile of evolution from the first months of
life are mandatory in order to make the distinction
between a developmental and an acquired process.
This step is time-consuming and is not always easy
to perform because case histories may be imprecise
and evolution profiles complicated, with periods of
progression, stagnation and regression in a limited
period of time in the same patient. In most cases,
the clinical evaluation will usefully be completed
by a neuropsychological and linguistic evaluation,
the tests administered depending on the age, col-
laboration and global level of the child. A behav-
ioral questionnaire to be completed by parents or
teachers is also very useful and should be encour-
aged in suspicion of behavioral troubles.
If the cognitive or behavioral profile suggests an
epileptic syndrome with CSWS, the second step
will be the realization of a long term video-EEG.
Awake and sleep recording will be separately ana-
lyzed. The analysis of awake records will focus on
the presence of interictal abnormalities (epilepti-
form discharges, slow dysrythmia), but also on the
presence of subtle seizures like absences or nega-
tive myoclonia. Myoclonia must be carefully
researched using video and surface EMG elec-
trodes, because the EEG correspondent does not
differ from interictal focal epileptiform abnormali-
ties (41). The sleep EEG must be analyzed qualita-
tively and quantitatively. The qualitative analysis
will focus on global organization of the EEG, the
diffusion of the epileptiform discharges, and asso-
ciated abnormalities like slow dysrythmia. The
goal of the quantitative analysis is to calculate a
spike-wave index score during slow-wave sleep.
The third step will be the realization of a cerebral
structural magnetic resonance imaging (MRI).
Lesions are found on MRI in about 20% of the
cases. These case belong to the subgroup of symp-
tomatic epilepsies with CSWS. Lesions usually
consist in clastic cortical lesions (encephalomala-
cia, polymicrogyria), but subcortical abnormalities
like ventricular enlargement or thalamic ischemic
perinatal injuries are occasionally found (20-22,
65). It must be emphasized that the chances to find
a structural lesion with MRI are very low if neuro-
logical examination does not show any sign of
cerebral palsy.
Genetic complementary investigations are indi-
cated in the presence of particular signs or symp-
toms, like profound mental retardation, micro-
cephaly or dysmorphic features. Indeed, the CSWS
pattern can be encountered in syndromes with
known chromosomal deletions affecting for
example the 15q region, or in Rett syndrome (66-
68).
More sophisticated investigations like PET with
FDG or MEG are indicated if specific questions are
raised, for example in the context of presurgical
evaluation or drug effect evaluation. 
Treatment
In the absence of any published placebo con-
trolled study on the use of AED in epilepsies with
CSWS, treatment of these epileptic conditions
relies upon expert-based consensus guidelines and
uncontrolled published series. The evaluation of a
drug effect is probably more difficult in epilepsies
with CSWS than in any other epileptic condition
because (1) clinical and EEG fluctuations with time
without any change of treatment are frequently
observed, and (2) the goals of the treatment is not
only to abolish the seizures with minimal side
effects, but also to obtain neuropsychological
improvement in decreasing the interictal epilepti-
form activity during sleep. This is why protocols of
treatment should include counts of seizures, neu-
ropsychological evaluations and prolonged video-
EEG sessions.
At the Venice colloquium in 1993 about CSWS
and related conditions, valproate (VPA) was pro-
posed as first choice drug, either in monotherapy or
in association with a benzodiazepine (32). It is the
opinion of the authors that VPA should no longer
be considered the drug of first choice, at least to try
to “clean up” the sleep EEG (VPA may be efficient
to treat associated seizures like atypical absences).
The positive effects of VPA relies on relatively old
series including few patients (69, 70). Data con-
cerning the effect of benzodiazepines on the EEG
are more convincing. De Negri et al. reported a
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remission of CSWS in 9 out of 15 patients with a
one-month intra rectal diazepam treatment (71) ;
among these 9 patients, 7 showed an improvement
in their neuropsychological evaluation after
6 months. Other authors reported similar efficacy
with clonazepam or clobazam (9, 26, 70).
Among the other old drugs, there is a consensus
stating that carbamazepine, phenobarbital and
diphantoin are usually inefficacious and may even
aggravate the EEG and clinical condition of chil-
dren with CSWS (5, 69). On the contrary, ethosux-
imide and sulthiame are old drugs which may be
helpful in reducing CSWS (69, 72-74), but sulthi-
ame is not available in Belgium.
Concerning the new AED, recent case studies
and small series suggest that topiramate and
levetiracetam in add-on treatment are useful in
some patients (75-78), but further studies are
needed to define the place of these drugs in the
treatment of CSWS.
It must be emphasized that the response to con-
ventional AED is often incomplete and/or transito-
ry. Corticosteroids seem to have more long lasting
effects. Four studies focusing on the effects of cor-
ticosteroids in epilepsies with CSWS were pub-
lished, using variable regimens. In the first study,
3 patients received either prednisone or hydrocorti-
sone during 4 to 12 months (69). In the second
study, 4 patients received early and prolonged
ACTH or corticosteroid therapy, with high initial
doses (79). In the third study, 2 patients received
high dose intravenous methylprednisolone pulses
for 3 days followed by a one-month oral pred-
nisolone cure (80). In the fourth study, 10 patients
received prednisone for 6 months, at relatively low
doses (1 mg/kg/day) (81). Improvement of lan-
guage, cognition and behavior was reported in all
but one patient of these 4 series. Clinical improve-
ment was at time spectacular, especially in children
treated relatively early in the course of the disease,
and was usually accompanied by an improvement
of the EEG, with complete disappearance of the
epileptiform activity in some cases. Some patients
relapsed during steroids withdrawal, the risk of
relapse seeming to be related to brief duration of
treatment. Thus relapse of CSWS during steroids
tapering is not the rule, and a unique cure may
arrest the disease. This potential benefit has to be
balanced with the well-known side effects of a long
term steroids therapy. Special concerns in children
are weight gain with Cushingoïd aspect, failure to
thrive and increased risk of bone fracture.
Concerning this last point, it must be emphasized
that the risk of bone fracture related to osteoporo-
sis is increased during the treatment, but disappears
within one year of stopping therapy (82).
Amongst the other therapeutic modalities,
authors have reported some benefits of intravenous
immunoglobulins or vagus nerve stimulation
(VNS) in limited series of patients (83-85).
Finally, surgery using multiple subpial transec-
tions has to be considered in refractory cases of
LKS. This technique developed by Franck Morell
as a surgical treatment of epileptic foci located in
eloquent cortex has indeed shown benefits only in
patients with a pure verbal auditive agnosia, and
not in other phenotypes of CSWS epilepsy (55, 86-
88). Good candidates are patients in whom a uni-
lateral perisylvian epileptic origin is suggested on
the basis of the non invasive presurgical evaluation.
MEG might be particularly useful in this perspec-
tive (57). Improvement of language after surgery
was reported in the majority of patients, but was
most likely to be seen years, rather than months,
after surgery, which raises the question of the nat-
ural evolution to recovery (87).
Long-term outcome
The CSWS phenomenon is age-related and will
remit usually before the age of 15 years. Thus the
long-term prognosis of the epilepsy is good, even
for patients with symptomatic epilepsy with
CSWS, for instance those presenting with cortical
malformations (20). On the other hand, the progno-
sis of intellectual functioning and language abili-
ties is much more variable. Improvement in lan-
guage dysfunction, mental retardation, and psychi-
atric disturbances generally occurs but the majority
of affected children never return to normal levels,
particularly in the verbal area and attention (3, 10).
Persistent impairment in verbal short-term memory
was demonstrated in patients after recovery from
LKS using functional imaging : when compared to
controls, patients showed decrease activation for an
immediate serial recall words task in those posteri-
or superior temporal gyri that were involved in the
epileptic focus during the active phase of the dis-
ease (89).
Outcome at adulthood has been recently report-
ed in 7 young adults. This study confirmed the
good prognosis of epilepsy, still one patient having
active epilepsy. The neuropsychological disorders
particular to each syndrome persisted. Only 2
patients had achieved normal schooling. Three
patients remained globally mentally deficient. The
intellectual functions of both patients with LKS
were normal ; however, their everyday lives were
disturbed by severe, disabling language distur-
bances (90).
Guidelines for treatment of epileptic syndromes
with CSWS
As pointed out in the previous sections of this
paper, epileptic syndromes with CSWS are very
heterogeneous not only for the clinical presentation
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but also for the presumed etiology. Therefore, the
treatment will be individualized in taking into
account the following considerations : (1) What is
the clinical phenotype ? Is it a true LKS or a less
severe type of cognitive or behavioral
dysfunction ? (2) How is the profile of evolution ?
Is it a rapid and massive regression or a develop-
mental delay with recent stagnation for the acquisi-
tion of new skills ? (3) What is the suspected etiol-
ogy ? Is it an idiopathic epilepsy with probable
complex genetic background or a symptomatic
epilepsy related to a structural brain lesion ? (4)
How is the EEG during slow sleep ? Is it a pattern
of a continuous generalized high amplitude spike-
waves activity with destructed background or an
important enrichment in focal epileptiform dis-
charges with preserved background ? (5) Are there
clinical epileptic seizures ? If yes, are they infre-
quent nocturnal tonic-clonic seizures or thousands
of daily brief seizures like atypical absences or
focal myoclonia ?
In the opinion of the authors, the general rules
for treatment are the followings :
(1) Avoid carbamazepine, oxcarbazepine, pheno-
barbital and diphantoin, and begin to taper off
these drugs if CSWS appeared in a patient
treated for epilepsy by one of these drugs.
(2) A benzodiazepine is the first line treatment,
associated with VPA in the presence of clinical
seizures.
(3) If this failed, and if the clinical profile is a
severe and rapid cognitive deterioration after
normal development (in particular verbal audi-
tive agnosia, i.e. LKS) in the absence of struc-
tural lesion on MRI, a corticosteroid cure has
still to be considered, and should be prolonged
for a period of at least 6 months in case of pos-
itive answer. In the other situations, therapeutic
trials with ethosuximide, topiramate and leve-
tiracetam are recommended before using
steroids. It is important to be aware that the
efficacy of each drug has to be monitored by
combined clinical and EEG evaluations, that
conclusions about efficacy of a drug may still
be drawn after a trial of 2 months, and that
relapse after initial positive answer is not infre-
quent. Monotherapy is rarely attained in these
cases, but tritherapy or quadritherapy should be
avoided considering the increasing risk of
cumulative side effects, in particular in the
domains of cognition and behavior.
(4) Surgery by multiple subpial transections should
be restricted to highly selected cases of LKS
with electrophysiological evidence of unilater-
al epileptogenic zone.
(5) Other therapeutic options like intravenous
immunoglobulins and VNS should be consid-
ered after failure of the previously considered
options.
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